MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an update. On December 10, 2025, MAIA Biotechnology announced a significant ...

Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in ...

The latest insider buying arrives as ateganosine continues to deliver encouraging results. These outcomes have strengthened internal and external confidence that MAIA’s novel telomere-targeting ...

Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) has issued an update. Shanghai Henlius Biotech, Inc. announced the approval of phase 2/3 ...

Ophirex announced that varespladib, which is also being developed as an oral rescue treatment for snakebite envenomation in ...

Depth Analysis of Bioseparation Systems Market, Highlighting Trends, Technologies, ESG Insights, and Growth Potential Through ...

A long-sought crackdown on outbound American investment in China is on the verge of becoming law after House lawmakers ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

The National Biotechnology Research and Development Agency has convened a multi-stakeholder review and validation workshop to ...

A long-sought crackdown on U.S. funding of China’s military and strategic industries is on the verge of becoming law after ...

The Muscular Dystrophy Association (MDA) announced today that John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), will deliver the keynote address at the 2026 MDA ...

Phase 1/2 Trial Confirms Safety With Repeated Dosing Supporting Further Development in Early-stage Disease and Combination Treatment Settings ATLANTA, GA - December 8, 2025 (NEWMEDIAWIRE) - GeoVax ...